Field intelligence
AI research, companies, regulatory moves, and clinical adoption across neurosurgery.
Independent intelligence for surgical AI
Neurosurgery.ai
Tracking the research, companies, tools, and clinical adoption signals shaping AI in neurosurgery.
A concise briefing every two weeks. No hype, no spam.
Latest Brief
Research, tools, and adoption signals in one read.
Segmentation gets boring, and why that matters
Issue 1 · July 19, 2026
A launch-format issue covering segmentation maturity, regulatory tracking, adoption friction, and the first Spinal Cord Watch.
Neurosurgery.ai Index
A curated tracker for AI-enabled neurosurgical tools.
The Index starts with a compact public table: category, use case, FDA/CE/NMPA status, evidence signal, and a clinical note. Its goal is not volume; it is a clean record that can be reviewed, cited, and improved over time.
| Tool area | Use case | Regulatory fields | Clinical note |
|---|---|---|---|
| Imaging AI | Tumor segmentation, detection, triage | FDA / CE / NMPA | Separate validated indication from marketing claims. |
| Spine AI | Alignment, measurement, planning | Clearance pathway, region, date | Workflow fit matters as much as measurement accuracy. |
| Spinal Cord Watch | IONM, Chiari, syrinx, intramedullary tumors | Mostly early evidence and research signals | The neglected middle ground between brain and spine AI. |
Two-layer focus
Broad enough to track the field, narrow enough to be useful.
Spinal cord depth
Intramedullary tumors, Chiari, syringomyelia, IONM, and under-covered spinal cord AI.
Professional boundary
No diagnosis, no patient advice, no image interpretation, and no clinical decision support.